Growth hormone mediators linked with unique phenotype of pediatric type 2 diabetes: TODAY analysis
USA: A post hoc secondary analysis of a randomized clinical trial (TODAY) of 398 participants with youth-onset type 2 diabetes (T2D) revealed that growth hormone mediators may be linked with the unique phenotype of pediatric T2D. The study, published in JAMA Network Open, suggests that changes in plasma growth hormone mediators are linked with loss […]